The IFITM protein family in adaptive immunity

Diana C Yánez, Susan Ross, Tessa Crompton, Diana C Yánez, Susan Ross, Tessa Crompton

Abstract

Interferon-inducible transmembrane (IFITM) proteins are a family of small homologous proteins, localized in the plasma and endolysosomal membranes, which confer cellular resistance to many viruses. In addition, several distinct functions have been associated with different IFITM family members, including germ cell specification (IFITM1-IFITM3), osteoblast function and bone mineralization (IFITM5) and immune functions (IFITM1-3, IFITM6). IFITM1-3 are expressed by T cells and recent experiments have shown that the IFITM proteins are directly involved in adaptive immunity and that they regulate CD4+ T helper cell differentiation in a T-cell-intrinsic manner. Here we review the role of the IFITM proteins in T-cell differentiation and function.

Keywords: T cell; T helper type 1; T helper type 2; differentiation; interferon-inducible transmembrane protein.

Conflict of interest statement

The authors have no competing interests.

© 2019 John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Chromosomal position of interferon‐inducible transmembrane (IFITM) genes, IFITM topology and cellular localization. (a) The cartoon illustrates the location and organization of IFITM gene clusters in mouse and human. Introns are represented by a horizontal brown rectangle. Exons are represented by vertical coloured rectangles, arrows below indicate the direction of transcription.4, 18 (b) The cartoon illustrates the proposed models of IFITM protein topology. First model suggests a conserved intracellular loop (CIL) between two transmembrane domains (TM) with extracellular C' and N' terminal domains. Second model shows a CIL between two intramembrane domains (IM) with intracellular C' and N' terminal domains. The third model proposes a CIL between IM and a TM with an intracellular N' and an extracellular C' terminal domain. These three topology models are predominant but alternative models have been proposed for specific IFITM protein topology depending on their function.1 (c) The cartoon illustrates the cellular localization of IFITM1–3 proteins. IFITM proteins have been shown to span several cellular membranes. IFITM1 is found in different intracellular compartments from IFITM2 and IFITM3 with little overlap.47, 59 IFITM1–3 can all be found on the plasma membrane, but IFITM1 has been shown to be the predominant IFITM associated with the plasma membrane and is also found in early endosomes.35, 60 IFITM2 and IFITM3 are predominately located intracellularly in late endosomes and lysosomes and co‐localize with Rab7, CD63 and lysosomal‐associated membrane protein (LAMP1).21 The illustrations in this figure are cartoons that are not drawn to scale.
Figure 2
Figure 2
Interferon‐inducible transmembrane (IFITM) proteins are involved in T helper type 1 (Th1) and Th2 differentiation. Cartoons show a not‐to‐scale graphical representation of the role of IFITM proteins in the regulation of Th1/Th2 differentiation.13 (a) In normal conditions, differential expression of IFITM proteins maintains the normal balance between Th1 and Th2 differentiation on activation of naive CD4+ T cells. (b) Upper panel: In the absence of IFITM proteins, the balance of the Th1/Th2 differentiation is altered on activation of naive CD4+ T cells. Differentiation of Th1 cells is promoted with higher expression of key Th1 regulators, while Th2 differentiation is suppressed. Lower panel: IFITM deficiency decreases allergic airway inflammation, with lower cellular infiltration, mucous secretion, and Th2 response in a mouse model of allergic airway disease (asthma).

References

    1. Zhao X, Li J, Winkler CA, An P, Guo JT. IFITM genes, variants, and their roles in the control and pathogenesis of viral infections. Front Microbiol 2018; 9:3228.
    1. Liao Y, Goraya MU, Yuan X, Zhang B, Chiu SH, Chen JL. Functional involvement of interferon‐inducible transmembrane proteins in antiviral immunity. Front Microbiol 2019; 10:1097.
    1. Bailey CC, Zhong G, Huang IC, Farzan M. IFITM‐family proteins: the cell's first line of antiviral defense. Annu Rev Virol 2014; 1:261–83.
    1. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR. Transcriptional and posttranscriptional regulation of interferon‐induced gene expression in human cells. Cell 1984; 38:745–55.
    1. Reid LE, Brasnett AH, Gilbert CS, Porter AC, Gewert DR, Stark GR et al A single DNA response element can confer inducibility by both α‐ and γ‐interferons. Proc Natl Acad Sci USA 1989; 86:840–4.
    1. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon‐inducible gene family. Eur J Biochem 1991; 199:417–23.
    1. Bedford JG, O'Keeffe M, Reading PC, Wakim LM. Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection. PLoS ONE 2019; 14:e0210132.
    1. Wakim LM, Gupta N, Mintern JD, Villadangos JA. Enhanced survival of lung tissue‐resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol 2013; 14:238–45.
    1. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL‐6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13:199–212.
    1. Lickert H, Cox B, Wehrle C, Taketo MM, Kemler R, Rossant J. Dissecting Wnt/β‐catenin signaling during gastrulation using RNA interference in mouse embryos. Development 2005; 132:2599–609.
    1. Furmanski AL, Barbarulo A, Solanki A, Lau CI, Sahni H, Saldana JI et al The transcriptional activator Gli2 modulates T‐cell receptor signalling through attenuation of AP‐1 and NFκB activity. J Cell Sci 2015; 128:2085–95.
    1. Amet T, Son YM, Jiang L, Cheon IS, Huang S, Gupta SK et al BCL6 represses antiviral resistance in follicular T helper cells. J Leukoc Biol 2017; 102:527–36.
    1. Yanez DC, Sahni H, Ross S, Solanki A, Lau CI, Papaioannou E et al IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation. Eur J Immunol 2019; 49:66–78.
    1. Saitou M, Barton SC, Surani MA. A molecular programme for the specification of germ cell fate in mice. Nature 2002; 418:293–300.
    1. Tanaka SS, Matsui Y. Developmentally regulated expression of mil‐1 and mil‐2, mouse interferon‐induced transmembrane protein like genes, during formation and differentiation of primordial germ cells. Gene Expr Patterns 2002; 2:297–303.
    1. Lange UC, Saitou M, Western PS, Barton SC, Surani MA. The fragilis interferon‐inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 2003; 3:1.
    1. Lange UC, Adams DJ, Lee C, Barton S, Schneider R, Bradley A et al Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol 2008; 28:4688–96.
    1. Zhang Z, Liu J, Li M, Yang H, Zhang C. Evolutionary dynamics of the interferon‐induced transmembrane gene family in vertebrates. PLoS ONE 2012; 7:e49265.
    1. Hickford D, Frankenberg S, Shaw G, Renfree MB. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genom 2012; 13:155.
    1. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. Interferon‐induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 2010; 84:12646–57.
    1. Yount JS, Karssemeijer RA, Hang HC. S‐Palmitoylation and ubiquitination differentially regulate interferon‐induced transmembrane protein 3 (IFITM3)‐mediated resistance to influenza virus. J Biol Chem 2012; 287:19631–41.
    1. Bailey CC, Kondur HR, Huang IC, Farzan M. Interferon‐induced transmembrane protein 3 is a type II transmembrane protein. J Biol Chem 2013; 288:32184–93.
    1. Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PP, Matsui Y. Regulation of expression of mouse interferon‐induced transmembrane protein like gene‐3, Ifitm3 (mil‐1, fragilis), in germ cells. Dev Dyn 2004; 230:651–9.
    1. Tanaka SS, Yamaguchi YL, Tsoi B, Lickert H, Tam PP. IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 2005; 9:745–56.
    1. Moffatt P, Gaumond MH, Salois P, Sellin K, Bessette MC, Godin E et al Bril: a novel bone‐specific modulator of mineralization. J Bone Miner Res 2008; 23:1497–508.
    1. Hanagata N, Li X, Morita H, Takemura T, Li J, Minowa T. Characterization of the osteoblast‐specific transmembrane protein IFITM5 and analysis of IFITM5‐deficient mice. J Bone Miner Metab 2011; 29:279–90.
    1. Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, Jeon D et al A single recurrent mutation in the 5'‐UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 2012; 91:343–8.
    1. Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, Becker J et al A mutation in the 5'‐UTR of IFITM5 creates an in‐frame start codon and causes autosomal‐dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 2012; 91:349–57.
    1. Hoyer‐Kuhn H, Semler O, Garbes L, Zimmermann K, Becker J, Wollnik B et al A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset. J Bone Miner Res 2014; 29:1387–91.
    1. Takahashi S, Doss C, Levy S, Levy R. TAPA‐1, the target of an antiproliferative antibody, is associated on the cell surface with the Leu‐13 antigen. J Immunol 1990; 145:2207–13.
    1. Evans SS, Lee DB, Han T, Tomasi TB, Evans RL. Monoclonal antibody to the interferon‐inducible protein Leu‐13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 1990; 76:2583–93.
    1. Levine S, Xian CY, Agocha B, Allopenna J, Welte K, Armstrong D et al Differential modulation of the CD‐2 and CD‐3 T cell activation pathways by a monoclonal antibody to Leu‐13. Cell Immunol 1991; 132:366–76.
    1. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody‐1 and Leu‐13 molecules. J Immunol 1992; 149:2841–50.
    1. Deblandre GA, Marinx OP, Evans SS, Majjaj S, Leo O, Caput D et al Expression cloning of an interferon‐inducible 17‐kDa membrane protein implicated in the control of cell growth. J Biol Chem 1995; 270:23860–6.
    1. Smith RA, Young J, Weis JJ, Weis JH. Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 2006; 7:113–21.
    1. Han JH, Lee S, Park YS, Park JS, Kim KY, Lim JS et al IFITM6 expression is increased in macrophages of tumor‐bearing mice. Oncol Rep 2011; 25:531–6.
    1. Wakim LM, Woodward‐Davis A, Liu R, Hu Y, Villadangos J, Smyth G et al The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J Immunol 2012; 189:3462–71.
    1. Infusini G, Smith JM, Yuan H, Pizzolla A, Ng WC, Londrigan SL et al Respiratory DC use IFITM3 to avoid direct viral infection and safeguard virus‐specific CD8+ T cell priming. PLoS ONE 2015; 10:e0143539.
    1. Andreu P, Colnot S, Godard C, Laurent‐Puig P, Lamarque D, Kahn A et al Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 2006; 66:1949–55.
    1. Wee YS, Weis JJ, Gahring LC, Rogers SW, Weis JH. Age‐related onset of obesity corresponds with metabolic dysregulation and altered microglia morphology in mice deficient for Ifitm proteins. PLoS ONE 2015; 10:e0123218.
    1. Yang G, Xu Y, Chen X, Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon‐gamma. Oncogene 2007; 26:594–603.
    1. Daniel‐Carmi V, Makovitzki‐Avraham E, Reuven EM, Goldstein I, Zilkha N, Rotter V et al The human 1–8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene. Int J Cancer 2009; 125:2810–9.
    1. Hisamatsu T, Watanabe M, Ogata H, Ezaki T, Hozawa S, Ishii H et al Interferon‐inducible gene family 1–8U expression in colitis‐associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Res 1999; 59:5927–31.
    1. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM et al The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139:1243–54.
    1. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C et al Identification of five interferon‐induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 2010; 84:8332–41.
    1. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ et al Distinct patterns of IFITM‐mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 2011; 7:e1001258.
    1. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV‐1 infection. J Virol 2011; 85:2126–37.
    1. Savidis G, Perreira JM, Portmann JM, Meraner P, Guo Z, Green S et al The IFITMs inhibit Zika virus replication. Cell Rep 2016; 15:2323–30.
    1. Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 2012; 8:e1002909.
    1. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE et al IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519–23.
    1. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH et al Interferon‐induced transmembrane protein‐3 genetic variant rs12252‐C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418.
    1. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X et al Early hypercytokinemia is associated with interferon‐induced transmembrane protein‐3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 2014; 111:769–74.
    1. Allen EK, Randolph AG, Bhangale T, Dogra P, Ohlson M, Oshansky CM et al SNP‐mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat Med 2017; 23:975–83.
    1. Randolph AG, Yip WK, Allen EK, Rosenberger CM, Agan AA, Ash SA et al Evaluation of IFITM3 rs12252 association with severe pediatric influenza infection. J Infect Dis 2017; 216:14–21.
    1. Wellington D, Laurenson‐Schafer H, Abdel‐Haq A, Dong T. IFITM3: how genetics influence influenza infection demographically. Biomed J 2019; 42:19–26.
    1. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 2011; 85:12881–9.
    1. Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M et al IFITM proteins incorporated into HIV‐1 virions impair viral fusion and spread. Cell Host Microbe 2014; 16:736–47.
    1. Xu Y, Yang G, Hu G. Binding of IFITM1 enhances the inhibiting effect of caveolin‐1 on ERK activation. Acta Biochim Biophys Sin (Shanghai) 2009; 41:488–94.
    1. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA et al IFITM‐2 and IFITM‐3 but not IFITM‐1 restrict Rift Valley fever virus. J Virol 2013; 87:8451–64.
    1. Weston S, Czieso S, White IJ, Smith SE, Kellam P, Marsh M. A membrane topology model for human interferon inducible transmembrane protein 1. PLoS ONE 2014; 9:e104341.
    1. Jia R, Xu F, Qian J, Yao Y, Miao C, Zheng YM et al Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol 2014; 16:1080–93.
    1. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M et al IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 2013; 9:e1003124.
    1. John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G et al The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol 2013; 87:7837–52.
    1. Amini‐Bavil‐Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M et al The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013; 13:452–64.
    1. Chesarino NM, McMichael TM, Hach JC, Yount JS. Phosphorylation of the antiviral protein interferon‐inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J Biol Chem 2014; 289:11986–92.
    1. Chesarino NM, McMichael TM, Yount JS. Regulation of the trafficking and antiviral activity of IFITM3 by post‐translational modifications. Future Microbiol 2014; 9:1151–63.
    1. Chesarino NM, McMichael TM, Yount JS. E3 Ubiquitin ligase NEDD4 promotes influenza virus infection by decreasing levels of the antiviral protein IFITM3. PLoS Pathog 2015; 11:e1005095.
    1. Kenney AD, McMichael TM, Imas A, Chesarino NM, Zhang L, Dorn LE et al IFITM3 protects the heart during influenza virus infection. Proc Natl Acad Sci USA 2019; 116:18607–12.
    1. Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song JY et al T cell memory. Skin‐resident memory CD8+ T cells trigger a state of tissue‐wide pathogen alert. Science 2014; 346:101–5.
    1. Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL et al The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 2016; 167, 1415–29. e19.
    1. Kichaev G, Bhatia G, Loh PR, Gazal S, Burch K, Freund MK et al Leveraging polygenic functional enrichment to improve GWAS power. Am J Hum Genet 2019; 104:65–75.
    1. Furmanski AL, Saldana JI, Ono M, Sahni H, Paschalidis N, D'Acquisto F et al Tissue‐derived hedgehog proteins modulate Th differentiation and disease. J Immunol 2013; 190:2641–9.
    1. Standing ASI, Yanez DC, Ross R, Crompton T, Furmanski AL. Frontline science: Shh production and Gli signaling is activated in vivo in lung, enhancing the Th2 response during a murine model of allergic asthma. J Leukoc Biol 2017; 102:965–76.
    1. Yanez DC, Lau CI, Chawda MM, Ross S, Furmanski AL, Crompton T. Hedgehog signaling promotes TH2 differentiation in naive human CD4 T cells. J Allergy Clin Immunol 2019; 144:1419–23.e1
    1. Choy DF, Modrek B, Abbas AR, Kummerfeld S, Clark HF, Wu LC et al Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 2011; 186:1861–9.
    1. Li X, Howard TD, Moore WC, Ampleford EJ, Li H, Busse WW et al Importance of hedgehog interacting protein and other lung function genes in asthma. J Allergy Clin Immunol 2011; 127:1457–65.
    1. Xu C, Zou C, Hussain M, Shi W, Shao Y, Jiang Z et al High expression of Sonic hedgehog in allergic airway epithelia contributes to goblet cell metaplasia. Mucosal Immunol 2018; 11:1306–15.
    1. Papaioannou E, Yanez DC, Ross S, Lau CI, Solanki A, Chawda MM et al Sonic Hedgehog signaling limits atopic dermatitis via Gli2‐driven immune regulation. J Clin Invest 2019; 129:3153–70.
    1. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML et al Genome‐wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis 2007; 13:807–21.
    1. Mo JS, Na KS, Yu JI, Chae SC. Identification of the polymorphisms in IFITM1 gene and their association in a Korean population with ulcerative colitis. Immunol Lett 2013; 156:118–22.
    1. Seo GS, Lee JK, Yu JI, Yun KJ, Chae SC, Choi SC. Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp Mol Med 2010; 42:99–104.
    1. Alteber Z, Sharbi‐Yunger A, Pevsner‐Fischer M, Blat D, Roitman L, Tzehoval E et al The anti‐inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota. Immunol Cell Biol 2018; 96:284–97.
    1. Miguel L, Owen DM, Lim C, Liebig C, Evans J, Magee AI et al Primary human CD4+ T cells have diverse levels of membrane lipid order that correlate with their function. J Immunol 2011; 186:3505–16.
    1. Marchetti M, Monier MN, Fradagrada A, Mitchell K, Baychelier F, Eid P et al Stat‐mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin‐dependent endocytosis of IFN receptors. Mol Biol Cell 2006; 17:2896–909.
    1. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, Mehta S et al Global regulator SATB1 recruits β‐catenin and regulates TH2 differentiation in Wnt‐dependent manner. PLoS Biol 2010; 8:e1000296.
    1. Yu Q, Sharma A, Oh SY, Moon HG, Hossain MZ, Salay TM et al T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA‐3 and repressing interferon‐γ . Nat Immunol 2009; 10:992–9.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir